The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
2021 · BMC Cancer · 28 citations
https://doi.org/10.1186/s12885-020-07727-y